ophthalmologytimes11h
FDA grants fast track status to FELIQS’ FLQ-101 for ROP
FELIQS plans to conduct a Phase 1b/2 study of FLQ-101 (tROPhy-1 study) both in the US and Japan in the first quarter of 2025.
ophthalmologytimes12h
LumiThera’s Valeda Light Delivery System receives marketing authorization from FDA
The Valeda Light Delivery System is for the treatment of patients with dry age-related macular degeneration (AMD).
ophthalmologytimes13h
Study: Aromatherapy decreased postoperative patient anxiety and pain associated with oculoplastic surgery
The investigators conducted a randomized controlled trial of 60 patients who underwent monitored anesthesia care sedation for ...
ophthalmologytimes16h
Phase 3 LUGANO Trial explores EYP-1901’s potential to reduce treatment burden in wet AMD Patients
In an interview with David Hutton of Ophthalmology Times, Ash Abbey, MD, discusses the Phase 3 LUGANO trial for EYP-1901 in treating wet age-related macular degeneration. Abbey discusses the trial’s ...